Sector--
Established Date15/02/2016
Listing Date25/03/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees34
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressYalelaan 62, 3584 CM Utrecht, The Netherlands
Business
IntroductionLAVA Therapeutics N.V. was incorporated in the Netherlands on February 15, 2016. The company is a clinical-stage immuno-oncology company dedicated to the rapid development of new cancer treatments that harness the immune system to save patients' lives. Utilizing the company's Gammabody platform, the company is developing a series of novel bispecific antibodies designed to harness the potency and precision of γ-δ (gd) T cells to elicit a powerful natural anti-tumor immune response and improve the prognosis of cancer patients.
